📣 VC round data is live. Check it out!

Corpovael Valuation Multiples

Discover revenue and EBITDA valuation multiples for Corpovael and similar public comparables like TRX Real Estate FII, Bb Premium Malls FII, Seritage Growth Properties, FaithNetwork Co and more.

Corpovael Overview

About Corpovael

Corpovael SA de CV is engaged in developing, building and commercializing accessible housing for the middle and lower level of the Mexicans. The company seeks new investment alternatives in other States of the Republic in order to provide a home for more Mexicans.


Founded

2007

HQ

Mexico

Employees

N/A

Financials (LTM)

Revenue: $301M
EBITDA: $47M

EV

$209M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Corpovael Financials

Corpovael reported last 12-month revenue of $301M and EBITDA of $47M.

In the same LTM period, Corpovael generated $71M in gross profit, $47M in EBITDA, and $23M in net income.

Revenue (LTM)


Corpovael P&L

In the most recent fiscal year, Corpovael reported revenue of $295M and EBITDA of $46M.

Corpovael is profitable as of last fiscal year, with gross margin of 24%, EBITDA margin of 15%, and net margin of 8%.

See analyst estimates for Corpovael
LTMLast FY202320242025202620272028
Revenue$301M$295M$260M$259M$293M
Gross Profit$71M$69M$70M$69M$69M
Gross Margin24%24%27%27%24%
EBITDA$47M$46M$33M$27M$33M
EBITDA Margin15%15%13%11%11%
EBIT Margin9%9%12%10%9%
Net Profit$23M$24M$17M$13M$24M
Net Margin8%8%7%5%8%
Net Debt—$73M———

Financial data powered by Morningstar, Inc.

Corpovael Stock Performance

Corpovael has current market cap of $135M, and enterprise value of $209M.

Market Cap Evolution


Corpovael's stock price is $0.46.

Corpovael share price increased by 4.8% in the last 30 days, and by 147.7% in the last year.

Corpovael has an EPS (earnings per share) of $0.08.

See more trading valuation data for Corpovael
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$209M$135M0.6%4.8%53.1%147.7%$0.08

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Corpovael Valuation Multiples

Corpovael trades at 0.7x EV/Revenue multiple, and 4.5x EV/EBITDA.

See NTM and 2027E valuation multiples for Corpovael

EV / Revenue (LTM)


Corpovael Financial Valuation Multiples

As of May 22, 2026, Corpovael has market cap of $135M and EV of $209M.

Corpovael has a P/E ratio of 5.9x.

LTMLast FY202320242025202620272028
EV/Revenue0.7x0.7x0.8x0.8x0.7x
EV/EBITDA4.5x4.6x6.4x7.6x6.4x
EV/EBIT7.5x7.7x6.9x8.3x7.7x
EV/Gross Profit2.9x3.0x3.0x3.0x3.0x
P/E5.9x5.6x7.9x10.1x5.7x
EV/FCF—4.2x2.8x19.5x4.2x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Corpovael Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Corpovael Margins & Growth Rates

Corpovael grew revenue by 5% and EBITDA by 6% in the last fiscal year.

In the most recent fiscal year, Corpovael reported gross margin of 24%, EBITDA margin of 15%, and net margin of 8%.

See estimated margins and future growth rates for Corpovael

Corpovael Margins

Last FY202420252026202720282029
Gross Margin24%27%24%24%
EBITDA Margin15%11%11%16%
EBIT Margin9%10%9%9%
Net Margin8%5%8%7%
FCF Margin17%4%17%—

Corpovael Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth5%(0%)13%6%
Gross Profit Growth5%(2%)0%5%
EBITDA Growth6%(16%)19%48%
EBIT Growth7%(17%)8%7%
Net Profit Growth(13%)(22%)78%(13%)
FCF Growth—(86%)362%—

Data powered by FactSet, Inc. and Morningstar, Inc.

Corpovael Operational KPIs

Corpovael's Rule of 40 is 22% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Corpovael's Rule of X is 31% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Corpovael
LTMLast FY202320242025202620272028
Rule of 4022%22%———
Bessemer Rule of X31%31%———
S&M Expenses to Revenue—8%9%10%8%
G&A Expenses to Revenue—0%0%0%0%
Opex to Revenue—14%15%17%14%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
TRX Real Estate FII9.6x———
Bb Premium Malls FII3.8x———
Seritage Growth Properties7.7x—(3.4x)—
FaithNetwork Co1.3x1.2x8.6x—
Fortinova Fastigheter10.0x—14.6x—
Deutsche Fachmarkt10.6x10.5x14.8x15.1x
AGROB Immobilien19.0x—27.8x—
Compañía de Inversiones La Española9.7x—11.3x—

This data is available for Pro users. Sign up to see all Corpovael competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Corpovael

When was Corpovael founded?Corpovael was founded in 2007.
Where is Corpovael headquartered?Corpovael is headquartered in Mexico.
Is Corpovael publicly listed?Yes, Corpovael is a public company listed on Bolsa Mexicana de Valores.
What is the stock symbol of Corpovael?Corpovael trades under CADUA ticker.
When did Corpovael go public?Corpovael went public in 2015.
Who are competitors of Corpovael?Corpovael main competitors include TRX Real Estate FII, Bb Premium Malls FII, Seritage Growth Properties, FaithNetwork Co, Fortinova Fastigheter, Deutsche Fachmarkt, AGROB Immobilien, Compañía de Inversiones La Española, Finbar Group, Amrep.
What is the current market cap of Corpovael?Corpovael's current market cap is $135M.
What is the current revenue of Corpovael?Corpovael's last 12 months revenue is $301M.
What is the current revenue growth of Corpovael?Corpovael revenue growth (NTM/LTM) is 6%.
What is the current EV/Revenue multiple of Corpovael?Current revenue multiple of Corpovael is 0.7x.
Is Corpovael profitable?Yes, Corpovael is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Corpovael?Corpovael's last 12 months EBITDA is $47M.
What is Corpovael's EBITDA margin?Corpovael's last 12 months EBITDA margin is 15%.
What is the current EV/EBITDA multiple of Corpovael?Current EBITDA multiple of Corpovael is 4.5x.
How many companies Corpovael has acquired to date?Corpovael hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Corpovael has invested to date?Corpovael hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Corpovael

Lists including Corpovael

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial